Skip to content

Clinical trials

Phase 2 Adenocarcinoma trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 2 Country / region: Brazil Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20111
20152
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status2
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Barretos Cancer Hospital1
Clovis Oncology, Inc.1
Eurofarma Laboratorios S.A.1
Novartis Pharmaceuticals1
Regeneron Pharmaceuticals1
Royal Marsden NHS Foundation Trust1
University of Campinas, Brazil1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma8
Carcinoma5
Colorectal Neoplasms2
Neoplasm Metastasis2
Neoplasms2
Rectal Neoplasms2
Adenocarcinoma, Mucinous1
Carcinoma, Renal Cell1
Digestive System Diseases1
Digestive System Neoplasms1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.